11.32
-0.66
(-5.51%)
At close: 4:00:01 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
Total Revenue
167,500.00
--
--
Operating Expense
103,239.00
98,551.00
111,026.00
Operating Income
64,261.00
-98,551.00
-111,026.00
Net Non Operating Interest Income Expense
3,442.00
1,966.00
2,028.00
Other Income Expense
--
-3,830.00
-5,942.00
Pretax Income
56,680.00
-100,415.00
-114,940.00
Net Income Common Stockholders
-18,266.00
-100,415.00
-114,940.00
Diluted NI Available to Com Stockholders
-17,546.00
-100,415.00
-114,940.00
Total Operating Income as Reported
64,261.00
-98,551.00
-111,026.00
Total Expenses
103,239.00
98,551.00
111,026.00
Net Income from Continuing & Discontinued Operation
55,233.00
-100,415.00
-114,940.00
Normalized Income
63,941.17
-96,585.00
-112,540.00
Interest Income
3,442.00
1,966.00
2,028.00
Net Interest Income
3,442.00
1,966.00
2,028.00
EBIT
64,261.00
-98,551.00
-111,026.00
EBITDA
67,829.00
-94,462.00
-107,206.00
Reconciled Depreciation
3,568.00
4,089.00
3,820.00
Net Income from Continuing Operation Net Minority Interest
55,233.00
-100,415.00
-114,940.00
Total Unusual Items Excluding Goodwill
-11,023.00
-3,830.00
-2,400.00
Total Unusual Items
-11,023.00
-3,830.00
-2,400.00
Normalized EBITDA
78,852.00
-90,632.00
-104,806.00
Tax Rate for Calcs
0.00
--
--
Tax Effect of Unusual Items
-2,314.83
--
--
12/31/2022 - 1/31/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MTSR Metsera, Inc.
30.03
-5.12%
SION Sionna Therapeutics, Inc.
20.28
+2.11%
SEPN Septerna, Inc.
11.55
+2.03%
ALMS Alumis Inc.
5.10
+1.39%
BCAX Bicara Therapeutics Inc.
13.12
-0.76%
AAPG Ascentage Pharma Group Internat
17.26
-3.31%
SLRN Acelyrin, Inc.
2.0600
+3.00%
THRD Third Harmonic Bio, Inc.
3.4300
-3.38%
APGE Apogee Therapeutics, Inc.
36.26
+2.14%
KYMR Kymera Therapeutics, Inc.
36.63
+4.21%